LABT Lakewood-amedex Biotherapeutics Inc.

Fundamentals / CIK 0002079272 / USD

Lakewood-amedex Biotherapeutics Inc. reported $3.60M in total assets through September 30, 2026 from SEC EDGAR filings.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open LABT in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

No annual income statement rows are available in SEC EDGAR CompanyFacts for LABT.

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-09-30 2025-06-30 2025-03-31
Cost of Revenue -- -- $507K -- -- --
Research & Development $733K $503K $182K $753K $147K $170K
Total Operating Expenses $1.51M $3.79M $887K $1.88M $637K $543K
Operating Income -$1.51M -$3.79M -$887K -$1.88M -$637K -$543K
EBITDA -$1.51M -$3.79M -$886K -$1.88M -$636K -$541K
Interest Income $36K $28K $1.1K $11K $5.4K $4.3K
Interest Expense $0 $11K $38K $38K $24K $1.3K
Net Income -$1.47M -$3.77M -$923K -$1.91M -$656K -$540K
Basic EPS -$0.62 -$2.75 -$0.20 -$3.46 -$1.66 -$0.15
Diluted EPS -$0.62 -$2.75 -$0.20 -$3.46 -$1.66 -$0.15
Basic Shares Outstanding 2.4M 1.4M 7.0M 696.9K 694.5K 6.9M
Diluted Shares Outstanding 2.4M 1.4M 7.0M 696.9K 694.5K 6.9M

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

No annual balance sheet rows are available in SEC EDGAR CompanyFacts for LABT.

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31
Cash & Cash Equivalents $2.82M $2.58M $12K $236K
Short-Term Investments $500K $2.00M -- --
Cash & Short-Term Investments $3.32M $4.58M $12K $236K
Total Current Assets $3.51M $4.85M $51K $305K
Property, Plant & Equipment, Net $5.7K $6.9K $8.1K $9.2K
Other Non-Current Assets $7.8K $7.8K $8.1K $8.1K
Total Non-Current Assets $84K $115K $146K $176K
Total Assets $3.60M $4.96M $196K $482K
Accounts Payable $240K $166K $548K $381K
Total Current Liabilities $673K $629K $3.03M $2.41M
Total Non-Current Liabilities $0 $0 $10K $41K
Total Liabilities $673K $629K $3.04M $2.45M
Total Debt (incl. Leases) $71K $102K $131K $160K
Common Stock $366 $217 $704 $70
Retained Earnings -$70.11M -$68.64M -$54.27M -$53.35M
Total Stockholders' Equity $2.93M $4.33M -$2.84M -$1.96M
Total Equity $2.93M $4.33M -$2.84M -$1.96M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

No annual cash flow statement rows are available in SEC EDGAR CompanyFacts for LABT.

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-09-30 2025-06-30 2025-03-31
Net Income -$1.47M -$3.77M -$923K -$1.91M -$656K -$540K
Depreciation & Amortization $1.2K $1.2K $1.2K $1.2K $1.2K $1.2K
Stock-Based Compensation $69K $61K $46K $1.20M $49K $54K
Change in Payables $74K -$382K $167K $199K -$131K $44K
Operating Cash Flow -$1.26M -$2.10M -$350K -$610K -$509K -$404K
Financing Cash Flow $0 $6.68M $125K $0 $1.30M $200K
Net Change in Cash $239K $2.57M -$225K -$610K $791K -$204K

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

No annual ratios & growth rows are available in SEC EDGAR CompanyFacts for LABT.

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-09-30 2025-06-30 2025-03-31
Current Ratio 5.22x 7.70x 0.02x -- -- --
Quick Ratio 4.94x 7.29x 0.00x -- -- --
Debt to Equity 0.02x 0.02x -- -- -- --
Source: SEC EDGAR CompanyFacts (CIK 0002079272) · from March 31, 2025 Data through September 30, 2026 · synced Nov 21, 2026, 05:14 UTC · Open in terminal